Alan Smyth

Professor of Child Health

University of Nottingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alan Smyth is a Professor of Child Health at the University of Nottingham, UK. His research primarily focuses on cystic fibrosis, specifically addressing gastrointestinal symptoms, infection prevention, and treatment regimens for related conditions. Recent articles include studies on the impact of therapies on gut microbiomes and the development of patient-reported outcome measures for cystic fibrosis management.

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (20)

Andrew Prayle

Clinical Associate Professor, Paediatric Respiratory Medicine

University of Nottingham School of Medicine

UNITED KINGDOM

Alan Smyth

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial

CF Tummy Tracker: A Cystic Fibrosis–Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden

Standards for the care of people with cystic fibrosis; establishing and maintaining health

A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)

Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis

Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions

Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study

Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries

Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome

A refresh of the top 10 research priorities in cystic fibrosis

Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis

Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis

Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis

Why and how should children be protected from the deluge of vaping related media and marketing overexposure?

Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis

Wheeze in the time of COVID-19: overcoming obstacles to an unusual diagnosis

Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis

Industry influence in healthcare harms patients: myth or maxim?

Exploring the challenges of accessing medication for patients with cystic fibrosis

Collaborators (20)

Andrew Prayle

Christabella Ng

Thomas Snelling

Carlo Castellani

André Schultz

Kevin W Southern

Amanda Tatler

Charlotte Addy

Doug Forrester

Caroline L. Hoad

Giles Major

Zoe Saynor

Chris van der Gast

Laura Fabbri

Don Sharkey

Isabelle DURIEU

Luca Marciani

R. Gisli Jenkins

Gwyneth Davies

Jobst F. Roehmel

Make your next move.